Chemomab Therapeutics Ltd. (CMMB)
2.59
-0.10
(-3.72%)
USD |
NASDAQ |
Sep 10, 16:00
2.59
0.00 (0.00%)
After-Hours: 18:56
Chemomab Therapeutics Price to Book Value : 2.161 for Sept. 10, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 2.244 |
| September 08, 2026 | 2.294 |
| September 04, 2026 | 2.261 |
| September 03, 2026 | 2.361 |
| September 02, 2026 | 2.278 |
| September 01, 2026 | 2.278 |
| August 31, 2026 | 2.269 |
| August 28, 2026 | 2.261 |
| August 27, 2026 | 2.269 |
| August 26, 2026 | 2.161 |
| August 25, 2026 | 1.919 |
| August 24, 2026 | 1.810 |
| August 21, 2026 | 1.802 |
| August 20, 2026 | 1.727 |
| August 19, 2026 | 1.744 |
| August 18, 2026 | 1.594 |
| August 17, 2026 | 1.602 |
| August 14, 2026 | 1.594 |
| August 13, 2026 | 1.585 |
| August 12, 2026 | 1.602 |
| August 11, 2026 | 1.585 |
| August 10, 2026 | 1.577 |
| August 07, 2026 | 1.610 |
| August 06, 2026 | 1.502 |
| August 05, 2026 | 1.46 |
| Date | Value |
|---|---|
| August 04, 2026 | 1.402 |
| August 03, 2026 | 1.352 |
| July 31, 2026 | 1.293 |
| July 30, 2026 | 1.276 |
| July 29, 2026 | 1.218 |
| July 28, 2026 | 1.193 |
| July 27, 2026 | 1.185 |
| July 24, 2026 | 1.135 |
| July 23, 2026 | 1.168 |
| July 22, 2026 | 1.193 |
| July 21, 2026 | 1.226 |
| July 20, 2026 | 1.251 |
| July 17, 2026 | 1.302 |
| July 16, 2026 | 1.268 |
| July 15, 2026 | 1.268 |
| July 14, 2026 | 1.276 |
| July 13, 2026 | 1.377 |
| July 10, 2026 | 1.452 |
| July 09, 2026 | 1.527 |
| July 08, 2026 | 1.644 |
| July 07, 2026 | 2.311 |
| July 06, 2026 | 2.002 |
| July 02, 2026 | 1.894 |
| July 01, 2026 | 1.418 |
| June 30, 2026 | 1.352 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioLineRx Ltd. | 0.809 |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 1.712 |
| Can-Fite BioPharma Ltd. | 1.590 |
| Galmed Pharmaceuticals Ltd. | 0.364 |
Price to Book Value Related Metrics
| Price | 2.59 |
| Earnings Yield | -39.40% |
| Market Cap | 18.77M |